Analyze Diet
The Journal of veterinary medical science2025; 87(6); 690-696; doi: 10.1292/jvms.25-0105

Minimal disruption of equine gut microbiota by intravenous cephalothin treatment.

Abstract: In horses, the gut microbiota plays a critical role in maintaining intestinal homeostasis and overall health, but antimicrobial administration can disrupt its balance, resulting in dysbiosis, which can cause antibiotic-associated diarrhea. This study assessed the impact of intravenous cephalothin sodium administration on the equine gut microbiota by using microbial amplicon sequencing targeting the 16S-ITS-23S rRNA operon. Fecal samples from 39 clinically normal horses, 16 antibiotic-treated horses (cephalothin, n=5; minocycline, n=5; metronidazole, n=6, each administered for 5 days), and seven colitis-affected horses were collected. Cephalothin had minimal effects on microbial diversity, as α-diversity and β-diversity did not differ significantly from those in clinically normal horses (P>0.05). In contrast, minocycline and metronidazole significantly disrupted the microbial composition. Colitis-affected horses exhibited severe microbial alterations, including reduced species richness. Among the 52 microbial families significantly altered in colitis horses, none showed significant changes in response to cephalothin, suggesting its gut-microbiota-friendly characteristics. Notably, Verrucomicrobia subdivision 3, associated with mucosal integrity, remained stable in the cephalothin group, whereas its relative abundance significantly decreased in the minocycline, metronidazole, and colitis groups (P<0.05). These findings suggest that cephalothin poses a lower risk of equine microbiota disruption than other antimicrobials, making it a safer option in veterinary practice. Cephalothin could help to maintain gut microbial balance while ensuring effective infection control and reducing gastrointestinal complications. This study provides valuable evidence for optimizing antimicrobial selection, supporting equine gut microbiota health.
Publication Date: 2025-04-18 PubMed ID: 40254462PubMed Central: PMC12169897DOI: 10.1292/jvms.25-0105Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study assesses the impact of a particular antibiotic, cephalothin, when administered intravenously on a horse’s gut microbiota. They found that it has minimal effects, providing evidence of a lower risk of disruption to the equine microbiota compared to other antimicrobials.

Study Design

  • The research study was set up to sample the fecal microbiota of horses undergoing different antibiotic treatments, as well as those suffering from colitis, versus clinically normal horses.
  • 39 clinically normal horses served as controls while another 16 were treated with various antibiotics (cepahlothin, minocycline, and metronidazole, all dosage administered for 5 days) and 7 were affected with colitis.
  • The researchers used microbial amplicon sequencing targeting the 16S-ITS-23S rRNA operon to study how the gut microbiota was impacted by these different conditions.

Findings

  • The researchers found that cephalothin appeared to have minimal effect on the gut microbiota. There were no significant differences in α-diversity and β-diversity (measures of microbial diversity in the gut) between horses treated with cephalothin and those that were clinically normal.
  • In contrast, the antibiotics minocycline and metronidazole significantly disrupted microbial composition of the gut. Colitis-afflicted horses likewise displayed markedly different microbiota profiles with reduced species richness, indicating a noteworthy impact of disease on these flora.

Interpretation

  • The fact that none of the microbial families significantly altered in the colitis-affected horses changed in response to cephalothin suggests this antibiotic has a minimal effect on the gut microbiota of the subjects.
  • In particular, the consistent abundance of Verrucomicrobia subdivision 3 – which is associated with supporting mucosal integrity – suggests that cephalothin might be a safer option compared to other antimicrobials which tend to significantly reduce the relative abundance of this important microbe group.
  • The researchers conclude that the use of cephalothin in veterinary practices could potentially ensure effective infection control while reducing the risk of gastrointestinal complications by maintaining gut microbial balance.
  • This study, thus, provides valuable evidence for the selection of antimicrobials, contributing to the optimization of veterinary therapeutic approaches and supporting equine gut microbiota health.

Cite This Article

APA
Kinoshita Y, Niwa H, Ueno T. (2025). Minimal disruption of equine gut microbiota by intravenous cephalothin treatment. J Vet Med Sci, 87(6), 690-696. https://doi.org/10.1292/jvms.25-0105

Publication

ISSN: 1347-7439
NlmUniqueID: 9105360
Country: Japan
Language: English
Volume: 87
Issue: 6
Pages: 690-696

Researcher Affiliations

Kinoshita, Yuta
  • Microbiology Division, Equine Research Institute, Japan Racing Association, Tochigi, Japan.
Niwa, Hidekazu
  • Microbiology Division, Equine Research Institute, Japan Racing Association, Tochigi, Japan.
Ueno, Takanori
  • Microbiology Division, Equine Research Institute, Japan Racing Association, Tochigi, Japan.

MeSH Terms

  • Animals
  • Horses / microbiology
  • Gastrointestinal Microbiome / drug effects
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / adverse effects
  • Horse Diseases / microbiology
  • Horse Diseases / drug therapy
  • Metronidazole / pharmacology
  • Metronidazole / administration & dosage
  • Colitis / veterinary
  • Colitis / microbiology
  • Colitis / drug therapy
  • Male
  • Minocycline / administration & dosage
  • Minocycline / pharmacology
  • Minocycline / adverse effects
  • RNA, Ribosomal, 16S / genetics
  • Female
  • Feces / microbiology

Conflict of Interest Statement

The authors declare no competing interests.

References

This article includes 31 references
  1. Arnold C, Pilla R, Chaffin K, Lidbury J, Steiner J, Suchodolski J. Alterations in the fecal microbiome and metabolome of horses with antimicrobial-associated diarrhea compared to antibiotic-treated and non-treated healthy case controls.. Animals (Basel) 2021;11:1807.
    doi: 10.3390/ani11061807pmc: PMC8235368pubmed: 34204371google scholar: lookup
  2. Barr BS, Waldridge BM, Morresey PR, Reed SM, Clark C, Belgrave R, Donecker JM, Weigel DJ. Antimicrobial-associated diarrhoea in three equine referral practices.. Equine Vet J 2013;45:154–158.
  3. Boniece WS, Wick WE, Holmes DH, Redman CE. In vitro and in vivo laboratory evaluation of cephalothin, a new broad spectrum antibiotic.. J Bacteriol 1962;84:1292–1296.
  4. Clausen PTLC, Aarestrup FM, Lund O. Rapid and precise alignment of raw reads against redundant databases with KMA.. BMC Bioinformatics 2018;19:307.
    doi: 10.1186/s12859-018-2336-6pmc: PMC6116485pubmed: 30157759google scholar: lookup
  5. Costa MC, Stämpfli HR, Arroyo LG, Allen-Vercoe E, Gomes RG, Weese JS. Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs.. BMC Vet Res 2015;11:19.
    doi: 10.1186/s12917-015-0335-7pmc: PMC4323147pubmed: 25644524google scholar: lookup
  6. Costa MC, Arroyo LG, Allen-Vercoe E, Stämpfli HR, Kim PT, Sturgeon A, Weese JS. Comparison of the fecal microbiota of healthy horses and horses with colitis by high throughput sequencing of the V3-V5 region of the 16S rRNA gene.. PLoS One 2012;7:e41484.
  7. d’Humières C, Delavy M, Alla L, Ichou F, Gauliard E, Ghozlane A, Levenez F, Galleron N, Quinquis B, Pons N, Mullaert J, Bridier-Nahmias A, Condamine B, Touchon M, Rainteau D, Lamazière A, Lesnik P, Ponnaiah M, Lhomme M, Sertour N, Devente S, Docquier JD, Bougnoux ME, Tenaillon O, Magnan M, Ruppé E, Grall N, Duval X, Ehrlich D, Mentré F, Denamur E, Rocha EPC, Le Chatelier E, Burdet C. Perturbation and resilience of the gut microbiome up to 3 months after β-lactams exposure in healthy volunteers suggest an important role of microbial β-lactamases.. Microbiome 2024;12:50.
    doi: 10.1186/s40168-023-01746-0pmc: PMC10929231pubmed: 38468305google scholar: lookup
  8. Davis JL. Pharmacologic principal.. 2017;p. 103. In: Equine Internal Medicine, 4th ed. (Reed SM, Bayly WM, Sellon DC eds.), Saunders, Philadelphia..
  9. Diab SS, Songer G, Uzal FA. Clostridium difficile infection in horses: a review.. Vet Microbiol 2013;167:42–49.
    doi: 10.1016/j.vetmic.2013.03.032pubmed: 23642413google scholar: lookup
  10. Edwards JE, Shetty SA, van den Berg P, Burden F, van Doorn DA, Pellikaan WF, Dijkstra J, Smidt H. Multi-kingdom characterization of the core equine fecal microbiota based on multiple equine (sub)species.. Anim Microbiome 2020;2:6.
    doi: 10.1186/s42523-020-0023-1pmc: PMC7807809pubmed: 33499982google scholar: lookup
  11. Ensink JM, van Klingeren B, Houwers DJ, Klein WR, Vulto AG. In-vitro susceptibility to antimicrobial drugs of bacterial isolates from horses in The Netherlands.. Equine Vet J 1993;25:309–313.
  12. Ferrer M, Méndez-García C, Rojo D, Barbas C, Moya A. Antibiotic use and microbiome function.. Biochem Pharmacol 2017;134:114–126.
    doi: 10.1016/j.bcp.2016.09.007pubmed: 27641814google scholar: lookup
  13. Harlow BE, Lawrence LM, Flythe MD. Diarrhea-associated pathogens, lactobacilli and cellulolytic bacteria in equine feces: responses to antibiotic challenge.. Vet Microbiol 2013;166:225–232.
    doi: 10.1016/j.vetmic.2013.05.003pubmed: 23769300google scholar: lookup
  14. Hothorn T, Bretz F, Westfall P. Simultaneous inference in general parametric models.. Biom J 2008;50:346–363.
    doi: 10.1002/bimj.200810425pubmed: 18481363google scholar: lookup
  15. Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota.. World J Gastroenterol 2015;21:8787–8803.
    doi: 10.3748/wjg.v21.i29.8787pmc: PMC4528021pubmed: 26269668google scholar: lookup
  16. Julliand V, Grimm P. Horse species symposium: the microbiome of the horse hindgut: history and current knowledge.. J Anim Sci 2016;94:2262–2274.
    doi: 10.2527/jas.2015-0198pubmed: 27285903google scholar: lookup
  17. Kauter A, Epping L, Semmler T, Antao EM, Kannapin D, Stoeckle SD, Gehlen H, Lübke-Becker A, Günther S, Wieler LH, Walther B. The gut microbiome of horses: current research on equine enteral microbiota and future perspectives.. Anim Microbiome 2019;1:14.
    doi: 10.1186/s42523-019-0013-3pmc: PMC7807895pubmed: 33499951google scholar: lookup
  18. Kinoshita Y, Niwa H, Uchida-Fujii E, Nukada T. Establishment and assessment of an amplicon sequencing method targeting the 16S-ITS-23S rRNA operon for analysis of the equine gut microbiome.. Sci Rep 2021;11:11884.
    doi: 10.1038/s41598-021-91425-7pmc: PMC8178347pubmed: 34088956google scholar: lookup
  19. Kinoshita Y, Niwa H, Uchida-Fujii E, Nukada T, Ueno T. Simultaneous daily fecal microbiota transplantation fails to prevent metronidazole-induced dysbiosis of equine gut microbiota.. J Equine Vet Sci 2022;114:104004.
    doi: 10.1016/j.jevs.2022.104004pubmed: 35526726google scholar: lookup
  20. Liepman RS, Swink JM, Habing GG, Boyaka PN, Caddey B, Costa M, Gomez DE, Toribio RE. Effects of Intravenous Antimicrobial Drugs on the Equine Fecal Microbiome.. Animals (Basel) 2022;12:12.
    pmc: PMC9030835pubmed: 35454258
  21. Macchione IG, Lopetuso LR, Ianiro G, Napoli M, Gibiino G, Rizzatti G, Petito V, Gasbarrini A, Scaldaferri F. Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders.. Eur Rev Med Pharmacol Sci 2019;23:8075–8083.
    pubmed: 31599433
  22. Marcelino VR, Clausen PTLC, Buchmann JP, Wille M, Iredell JR, Meyer W, Lund O, Sorrell TC, Holmes EC. CCMetagen: comprehensive and accurate identification of eukaryotes and prokaryotes in metagenomic data.. Genome Biol 2020;21:103.
    doi: 10.1186/s13059-020-02014-2pmc: PMC7189439pubmed: 32345331google scholar: lookup
  23. Marijon P, Chikhi R, Varré JS. yacrd and fpa: upstream tools for long-read genome assembly.. Bioinformatics 2020;36:3894–3896.
  24. Matsuda Y, Hobo S, Naito H. Transferability of cephalothin to the alveolar cavity in thoroughbreds.. J Vet Med Sci 1999;61:209–212.
    doi: 10.1292/jvms.61.209pubmed: 10331190google scholar: lookup
  25. McKinney CA, Bedenice D, Pacheco AP, Oliveira BCM, Paradis MR, Mazan M, Widmer G. Assessment of clinical and microbiota responses to fecal microbial transplantation in adult horses with diarrhea.. PLoS One 2021;16:e0244381.
  26. Mendelson J, Portnoy J, Sigman H, Dick V. Pharmacology of cephalothin in the biliary tract of humans.. Antimicrob Agents Chemother 1974;6:659–665.
    doi: 10.1128/AAC.6.6.659pmc: PMC444715pubmed: 4451341google scholar: lookup
  27. Nomura M, Kuroda T, Tamura N, Muranaka M, Niwa H. Mortality, clinical findings, predisposing factors and treatment of Clostridioides difficile colitis in Japanese thoroughbred racehorses.. Vet Rec 2020;187:e14.
    doi: 10.1136/vr.105605pubmed: 32201380google scholar: lookup
  28. Oksanen J, Blanchet FG, Friendly M, Kindt R, Legendre P, McGlinn D, Minchin PR, O’Hara RB, Simpson GL, Solymos P, Stevens MHH, Szoecs E, Wagner H. vegan: Community Ecology Package.. 2019. https://CRAN.R-project.org/package=vegan [accessed on March 1, 2025].
  29. Ratzan KR, Ruiz C, Irvin GL. Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease.. Antimicrob Agents Chemother 1974;6:426–431.
    doi: 10.1128/AAC.6.4.426pmc: PMC444665pubmed: 4157339google scholar: lookup
  30. Shen W, Le S, Li Y, Hu F. SeqKit: a cross-platform and ultrafast toolkit for FASTA/Q file manipulation.. PLoS One 2016;11:e0163962.
  31. Wickham H. ggplot2: Elegant Graphics for Data Analysis.. 2016. https://ggplot2.tidyverse.org [accessed on March 1, 2025].